 Periodate oxidative method for attachment of biomolecules to medical device surfaces |
| OF THE INVENTION As used in the specification and claims hereof, the following terms have the ... |
|
| Self-aligning peptides modeled on human elastin and other fibrous proteins |
| OF PREFERRED EMBODIMENTS The present invention is directed to unique polypeptides modeled on human ... |
|
| Prosthetic devices including elastin or elastin-based materials |
| It is a specific object of the invention to provide an elastin-based prosthetic device suitable for ... |
|
| Peptides containing N-substituted L-amino acids for preventing .beta.-strand association |
| The invention claimed is: 1. A peptide comprising a peptide, wherein: (a) said peptide comprises a .... |
|
| Lectins and antiretroviral drugs containing the lectins as active ingredient |
| OF THE INVENTION The lectins of the present invention are obtained from the plants of the class D... |
|
| Activated dendritic cells and methods for their activation |
| The present invention pertains to a method of activating dendritic cells to enhance antigen ... |
|
| Methods and compositions for obtaining mature dendritic cells |
| OF THE INVENTION This invention relates to methods and compositions useful for promoting the ... |
|
| Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| It has now been discovered that these and other objectives can be achieved by the present invention,... |
|
| Ligand for vascular endothelial growth factor receptor |
| We claim: 1. A compound comprising amino acid sequence Glu-Ile-Glu-Trp-Tyr-Ser-Trp-Val-Thr-His-Gly-M... |
|
|
Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
| Details |
Inventors: Bruno, Roberto Luis; Falci, Marcio;
Assignee: Laboratorios Biosintetica LTDA. (Taboao Da Serra, BR)
Primary Examiner: Kim; Vickie
Assistant Examiner:
Attorney, Agent or Firm: Duane Morris LLP
It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing.It is of the utmost importance to prevent the increase of endogenous homocysteine.High levels of homocysteine in blood, caused by genetical error and further biologic circumstances impart damaging consequences upon the human organism (occlusion of blood vessels, ocular modifications, osteoporosis and nervous system). |
|
DETAILED DESCRIPTION The invention claimed is: 1.
An oral pharmaceutical formulation comprising phytosterols and isomers thereof, folic acid, cyanocobalamine, pyridoxine and dietetic alimentary fibers intended for the treatment and prophylaxis of hypercholesteremia and hyperhomocysteinemia, wherein said phytosterol is present in an amount of about 2.
7% to about 3.
6% by weight; said folic acid is present in an amount of about 0.
001% to about 0.
002% by weight; said cyanocobalamine is present in an amount of about 0.
0005% to about 0.
001% by weight; said pyridoxine is present in an amount of about 0.
025% to about 0.
05% by weight; and said dietary fiber is present in about 26.
1% to about 33.
0% by weight.
2.
An oral composition for reducing hypercholesteremia and high blood homocysteine levels comprising an admixture of a phytosterol seleted from the group consisting of ergosterol, stigmasterol, betasitosterol, campesterol, betasitostanol, and isomers thereof; folic acid; cyanocobalamine; pyridoxine; and dietary fiber, wherein said phytosterol is present in an amount of about 2.
7% to about 3.
6% by weight; said folic acid is present in an amount of about 0.
001% to about 0.
002% by weight; said cyanocobalamine is present in an of about 0.
0005% to about 0.
001% by weight; said pyridoxine is present in an amout of about 0.
025% to about 0.
05% by weight; and said dietary fiber is present in about 26.
1% to about 33.
0% by weight.
3.
The composition of claim 2, wherein said composition is a pharmaceutical composition formulated as a powder, a sugar-coated pill, a capsule, a tablet, a paste, an emulsion, or a granulate.
4.
The composition of claim 2, wherein said dietary fiber is beet fiber.
5.
The composition of claim 2, wherein said phytosterol is betasitosterol.
6.
The composition of claim 2, wherein said composition is in the form of a bar.
7.
The composition of claim 6, wherein said bar further comprises whole milk, oat flakes, rice crispies, fruit pulp, flavoring, fumaric acid, salt, glucose syrup, liquid sugar, soy lecithin and cocoa fat
|
| Related patents |
|
|
Stimulation of chemotaxis by chemotactic peptides
Accordingly, it is an object of this invention to provide a synthetic material having chemotactic properties towards cells such as fibroblasts and endothelial cells. It ...
|
|
|
Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic heart valve having an improved resistance to post-implantation ...
|
|
|
Diagnosis of Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams syndrome map to the elastin gene and that molecular variants of the ...
|
|
|
Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic heart valve having an improved resistance to post-implantation ...
|
|
|
Method for bonding or fusion of biological tissue and material
Biological materials are joined, repaired or fused by heating the material in proximity to a mechanical support. In the preferred embodiment, the mechanical support ...
|
|
|
Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome
OF THE INVENTION The present invention is directed to the determination that SVAS and Williams syndrome map to the elastin gene and that molecular variants of the ...
|
|
|
Biological material pre-fixation treatment
OF PREFERRED EMBODIMENTS In one aspect, the present invention relates to an improved bioprosthetic heart valve having an improved resistance to post-implantation ...
|
|
|
Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
OF THE INVENTION The present invention covers a process that thoroughly removes intact cells from body tissues such as vascular structures including the porcine heart ...
|
|
|
Barrier webs having bioactive surfaces
What is claimed is: 1. A bioactive substrate comprising: a support; and a bioactive surface thereon, wherein the bioactive surface comprises: a shear-thinable, ...
|
|
|
Biopolymer foams for use in tissue repair and reconstruction
OF THE INVENTION The present invention features biopolymer foams, composite biopolymer foams, biocompatible constructs comprising biopolymer foams and extracellular ...
|
|
|
Drugs 
